Genomic Health (GHDX) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Income (loss) before income taxes: -14.81M
Today's EPS Names:
TFS, PBNK, FNRN, More
Financial Fact:
Income (loss) before income taxes: -14.81M
Today's EPS Names:
TFS, PBNK, FNRN, More
Join SI Premium – FREE
Genomic Health (NASDAQ: GHDX) reported Q2 EPS of ($0.08), $0.02 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $85.5 million versus the consensus estimate of $86.08 million.
GUIDANCE:
Genomic Health sees FY2017 revenue of $345-355 million, versus the consensus of $356.1 million.
For earnings history and earnings-related data on Genomic Health (GHDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TFS Financial (TFSL) Reports In-Line Q4 EPS
- AptarGroup (ATR) Tops Q3 EPS by 5c
- Rhinebeck Bancorp (RBKB) Tops Q3 EPS by 21c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
